"10.1371_journal.pone.0129291","plos one","2015-06-05T00:00:00Z","Simona Perga; Alessandra Giuliano Albo; Katarzyna Lis; Nicoletta Minari; Sara Falvo; Fabiana Marnetto; Marzia Caldano; Raffaella Reviglione; Paola Berchialla; Marco A Capobianco; Maria Malentacchi; Davide Corpillo; Antonio Bertolotto","Neurology Unit 2 & Regional Referral Multiple Sclerosis Centre (CReSM), San Luigi University Hospital, Orbassano, Italy; ABLE Biosciences, Bioindustry Park Silvano Fumero SpA, Colleretto Giacosa, Italy; LIMA, Bioindustry Park Silvano Fumero SpA, Colleretto Giacosa, Italy; Neuroscience Institute Cavalieri Ottolenghi (NICO), c/o San Luigi University Hospital, Orbassano, Italy; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy","Conceived and designed the experiments: SP AGA AB. Performed the experiments: AGA KL NM SF FM MC RR DC. Analyzed the data: SP AGA NM SF DC PB. Contributed reagents/materials/analysis tools: NM. Wrote the paper: SP AGA DC AB SF. Obtained patients' informed consent: AB. Performed clinical data gathering and clinical classification of patients: AB MM MAC.","Dr. Alessandra Giuliano-Albo has nothing to declare. Dr. Perga Simona received speaker honoraria from BiogenIdec, and her institution has received grant support from the Italian Multiple Sclerosis Society and Italian Ministry of Healthy. Dr. Katarzyna Lis has nothing to declare. MSc Nicoletta Minari has nothing to declare. Dr. Sara Falvo has nothing to declare. Dr. Fabiana Marnetto received speaker honoraria from Biogen Idec. Dr. Marzia Caldano received speaker honoraria from Biogen Idec and Teva. MSc Raffaella Reviglione has nothing to declare. Dr. Marco Capobianco received consultation fees and speaking fees from Biogen Idec, TEVA, Genzyme, and Novartis. Dr. Maria Malentacchi received speaker honoraria from Biogen Idec. Dr. Davide Corpillo has nothing to declare. Dr. Antonio Bertolotto received honoraria for serving in the scientific advisory boards of Bayer, BiogenIdec, Genzyme, and TEVA and received speaker honoraria from BiogenIdec, Genzyme, and Novartis; his institution has received grant support from Bayer, BiogenIdec, Merck, Novartis, from the Italian Multiple Sclerosis Society, Associazione Ricerca Biomedica ONLUS, and San Luigi ONLUS. Dr. Paola Berchialla has nothing to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","06","Simona Perga","SP",13,TRUE,3,8,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
